FULVESTRANT

Clinical trials for FULVESTRANT explained in plain language.

Never miss a new study

Get alerted when new FULVESTRANT trials appear

Sign up with your email to follow new studies for FULVESTRANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug OP-3136 enters first human tests for tough cancers

Disease control Recruiting now

This early-phase study tests a new drug called OP-3136 in people with advanced breast, lung, or prostate cancers that have stopped responding to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors or slow cancer growth. About 180 adults will…

Matched conditions: FULVESTRANT

Phase: PHASE1 • Sponsor: Olema Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 14, 2026 12:04 UTC

FULVESTRANT

Get alerted when new FULVESTRANT trials appear

New drug OP-3136 enters first human tests for tough cancers